You are here

Controversies In Prostate Cancer Treatment & Screening (3.27.19)

March 20, 2019

Jenny Donovan, PhD, FMedSciSocial scientist Jenny Donovan, PhD, FMedSci, a visiting scholar at the Durham VA Health System's Cooperative Studies Program Epidemiology Center (CSPEC) and Duke University, will deliver a talk on "Randomized trials for controversies in prostate cancer treatment and screening: recruitment and outcomes from the ProtecT trial of surgery, radiotherapy and active monitoring treatments and CAP trial of PSA testing" on Wednesday, March 27, at 5:30 p.m. in the Trent-Semans Great Hall.  A reception will follow.

Donovan, a professor of Social Medicine at the University of Bristol in the UK, works in the interdisciplinary area of Health Services Research (HSR). Within HSR, Donovan’s research interests are in people's experiences of illness and health care and the acceptability of healthcare interventions. She runs a large research program in prostate cancer, including the $14 million UK National Health Service-funded ProtecT (Prostate testing for cancer and Treatment) study, which is evaluating the effectiveness of treatments for localised (screen-detected) prostate cancer.

Donovan's other research interests are in perceptions of arthritis, compliance with medications, urinary incontinence, and research to improve the design and conduct of randomised controlled trials of healthcare interventions using a qualitative research method. She leads a program of qualitative research integrated in randomized trials to improve recruitment and informed consent through the QuinteT Recruitment Intervention, as well as other studies to understand issues in suicide prevention and reduction of over-treatment. She is an Emeritus NIHR Senior Investigator, Fellow of the UK Academy of Medical Sciences (FMedSci), Academician of the UK Academy of Social Sciences (AcSS), Fellow of the UK Faculty of Public Heath, and was awarded an OBE in 2013 for services to social medicine.